Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madsbad

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Diabete & Metabolisme|December 1, 1985
The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabeticsT Krarup, S Madsbad, L Regeur, et al.
Infection|July 1, 1988
Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patientsH Kjersem, J Hilsted, S Madsbad, et al.
Regulatory Peptides|June 25, 2010
Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitisF K Knop, T Vilsbøll, S Larsen, et al.
Lancet (London, England)|August 26, 1998
Effect of starch-free bread on metabolic control in type 2 diabetesB Stilling, J Mehlsen, O Hamberg, et al.
Acta Medica Scandinavica|January 1, 1981
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitusS Madsbad, T Krarup, P McNair, et al.
Diabetes Care|June 7, 2000
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1T Vilsbøll, M B Toft-Nielsen, T Krarup, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1982
No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathyJ Hilsted, S Madsbad, T Krarup, et al.
Contraception|March 15, 2000
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptivesK R Petersen, E Christiansen, S Madsbad, et al.
Diabetes, Obesity & Metabolism|January 7, 2011
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the futureS Madsbad, U Kielgast, M Asmar, et al.
Diabetologia|January 1, 1980
Islet-cell antibodies and beta-cell function in insulin-dependent diabeticsS Madsbad, G F Bottazzo, A G Cudworth, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Diabete & Metabolisme|December 1, 1985
The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabeticsT Krarup, S Madsbad, L Regeur, et al.
Infection|July 1, 1988
Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patientsH Kjersem, J Hilsted, S Madsbad, et al.
Regulatory Peptides|June 25, 2010
Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitisF K Knop, T Vilsbøll, S Larsen, et al.
Lancet (London, England)|August 26, 1998
Effect of starch-free bread on metabolic control in type 2 diabetesB Stilling, J Mehlsen, O Hamberg, et al.
Acta Medica Scandinavica|January 1, 1981
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitusS Madsbad, T Krarup, P McNair, et al.
Diabetes Care|June 7, 2000
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1T Vilsbøll, M B Toft-Nielsen, T Krarup, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1982
No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathyJ Hilsted, S Madsbad, T Krarup, et al.
Contraception|March 15, 2000
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptivesK R Petersen, E Christiansen, S Madsbad, et al.
Diabetes, Obesity & Metabolism|January 7, 2011
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the futureS Madsbad, U Kielgast, M Asmar, et al.
Diabetologia|January 1, 1980
Islet-cell antibodies and beta-cell function in insulin-dependent diabeticsS Madsbad, G F Bottazzo, A G Cudworth, et al.
Pageof 23